RETRACTED: Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route
- DOI
- 10.3390/nano10071270
- Published
- 2020-06-29
- Container
- Nanomaterials
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/nano10071270,
title = {RETRACTED: Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route},
author = {Osama Ahmed and Usama A. Fahmy and Shaimaa Badr-Eldin and Hibah Aldawsari and Zuhier Awan and Hani Asfour and Ahmed Kammoun and Giuseppe Caruso and Filippo Caraci and Anas Alfarsi and Raniyah A. Al-Ghamdi and Rawan A. Al-Ghamdi and Nabil Alhakamy},
year = {2020},
journal = {Nanomaterials},
doi = {10.3390/nano10071270},
url = {https://doi.org/10.3390/nano10071270}
}RIS
TY - JOUR TI - RETRACTED: Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route AU - Osama Ahmed AU - Usama A. Fahmy AU - Shaimaa Badr-Eldin AU - Hibah Aldawsari AU - Zuhier Awan AU - Hani Asfour AU - Ahmed Kammoun AU - Giuseppe Caruso AU - Filippo Caraci AU - Anas Alfarsi AU - Raniyah A. Al-Ghamdi AU - Rawan A. Al-Ghamdi AU - Nabil Alhakamy PY - 2020 JO - Nanomaterials DO - 10.3390/nano10071270 UR - https://doi.org/10.3390/nano10071270 ER -
APA
Ahmed, O., Fahmy, U. A., Badr-Eldin, S., Aldawsari, H., Awan, Z., Asfour, H., Kammoun, A., Caruso, G., Caraci, F., Alfarsi, A., Al-Ghamdi, R. A., Al-Ghamdi, R. A., & Alhakamy, N. (2020). RETRACTED: Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route. Nanomaterials. https://doi.org/10.3390/nano10071270
Source records
- crossref · retrieved 2026-11-10T07:36:20.784Z